Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trial
Acute respiratory distress syndrome (ARDS) in COVID-19 is associated with high mortality.
Mesenchymal stem cells are known to exert immunomodulatory and anti-inflammatory …
Mesenchymal stem cells are known to exert immunomodulatory and anti-inflammatory …
[PDF][PDF] Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trial
G Lanzoni, E Linetsky, D Correa, SM Cayetano… - 2021 - pbkm.pl
Acute respiratory distress syndrome (ARDS) in COVID-19 is associated with high mortality.
Mesenchymal stem cells are known to exert immunomodulatory and anti-inflammatory …
Mesenchymal stem cells are known to exert immunomodulatory and anti-inflammatory …
Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trial
G Lanzoni, E Linetsky, D Correa… - 2021 - digitalcommons.fiu.edu
Acute respiratory distress syndrome (ARDS) in COVID-19 is associated with high mortality.
Mesenchymal stem cells are known to exert immunomodulatory and anti-inflammatory …
Mesenchymal stem cells are known to exert immunomodulatory and anti-inflammatory …
[PDF][PDF] Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trial
G Lanzoni, E Linetsky, D Correa, SM Cayetano… - 2021 - therapeuticsolutionsint.com
Acute respiratory distress syndrome (ARDS) in COVID-19 is associated with high mortality.
Mesenchymal stem cells are known to exert immunomodulatory and anti-inflammatory …
Mesenchymal stem cells are known to exert immunomodulatory and anti-inflammatory …
[HTML][HTML] Umbilical cord mesenchymal stem cells for COVID‐19 acute respiratory distress syndrome: A double‐blind, phase 1/2a, randomized controlled trial
G Lanzoni, E Linetsky, D Correa… - Stem Cells …, 2021 - search.proquest.com
Acute respiratory distress syndrome (ARDS) in COVID‐19 is associated with high mortality.
Mesenchymal stem cells are known to exert immunomodulatory and anti‐inflammatory …
Mesenchymal stem cells are known to exert immunomodulatory and anti‐inflammatory …
Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trial.
G Lanzoni, E Linetsky, D Correa… - Stem Cells …, 2021 - europepmc.org
Acute respiratory distress syndrome (ARDS) in COVID‐19 is associated with high mortality.
Mesenchymal stem cells are known to exert immunomodulatory and anti‐inflammatory …
Mesenchymal stem cells are known to exert immunomodulatory and anti‐inflammatory …
[PDF][PDF] Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trial
G Lanzoni, E Linetsky, D Correa, SM Cayetano… - 2021 - newswise.com
Acute respiratory distress syndrome (ARDS) in COVID-19 is associated with high mortality.
Mesenchymal stem cells are known to exert immunomodulatory and anti-inflammatory …
Mesenchymal stem cells are known to exert immunomodulatory and anti-inflammatory …
Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trial
G Lanzoni, E Linetsky, D Correa, SM Cayetano… - Stem Cells …, 2021 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Acute respiratory distress syndrome (ARDS) in
COVID-19 is associated with high mortality. Mesenchymal stem cells are known to exert …
COVID-19 is associated with high mortality. Mesenchymal stem cells are known to exert …
[PDF][PDF] Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trial
G Lanzoni, E Linetsky, D Correa, SM Cayetano… - 2021 - go.cellcare.com.au
Acute respiratory distress syndrome (ARDS) in COVID-19 is associated with high mortality.
Mesenchymal stem cells are known to exert immunomodulatory and anti-inflammatory …
Mesenchymal stem cells are known to exert immunomodulatory and anti-inflammatory …
[PDF][PDF] Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trial
G Lanzoni, E Linetsky, D Correa, SM Cayetano… - 2021 - scienceopen.com
Acute respiratory distress syndrome (ARDS) in COVID-19 is associated with high mortality.
Mesenchymal stem cells are known to exert immunomodulatory and anti-inflammatory …
Mesenchymal stem cells are known to exert immunomodulatory and anti-inflammatory …